Revelation Biosciences, Inc. (REVB)
Automate Your Wheel Strategy on REVB
With Tiblio's Option Bot, you can configure your own wheel strategy including REVB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol REVB
- Rev/Share 0.0102
- Book/Share 4.1599
- PB 0.2403
- Debt/Equity 0.0
- CurrentRatio 6.9196
- ROIC -0.7502
- MktCap 1699184.0
- FreeCF/Share -3.7934
- PFCF -0.1694
- PE -0.2426
- Debt/Assets 0.0
- DivYield 0
- ROE -1.9447
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
Published: October 29, 2025 by: Accesswire
Sentiment: Neutral
SAN DIEGO, CA / ACCESS Newswire / October 29, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the October 15, 2025 Special Meeting of Stockholders of Revelation Biosciences, Inc. (the "Company"), which was adjourned to October 29, 2025 has been canceled due to technical difficulty outside of the Company's control with stockholders being unable to vote all of their shares. The Company has decided to cancel the adjourned Special Meeting scheduled for today, October 29, at 12pm ET and to set a new record date of October …
Read More
About Revelation Biosciences, Inc. (REVB)
- IPO Date 2020-11-17
- Website https://www.revbiosciences.com
- Industry Biotechnology
- CEO James M. Rolke
- Employees 8